Biotech Initiatives Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 9.89 M
as on 16-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 10.25 Cr
as on 16-12-2024
- Satisfied Charges ₹ 1.35 Cr
as on 16-12-2024
- Revenue 1.84%
(FY 2019)
- Profit 26.96%
(FY 2019)
- Ebitda 84.76%
(FY 2019)
- Net Worth 17.72%
(FY 2019)
- Total Assets 202.77%
(FY 2019)
About Biotech Initiatives
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 9.89 M.
The company currently has active open charges totaling ₹10.25 Cr. The company has closed loans amounting to ₹1.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deepak Prajapati and Poonam Prajapati serve as directors at the Company.
- CIN/LLPIN
U01400MH2014PTC253243
- Company No.
253243
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2014
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biotech Initiatives?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Prajapati  | Director | 14-May-2015 | Current |
| Poonam Prajapati | Director | 02-Apr-2016 | Current |
Financial Performance of Biotech Initiatives.
Biotech Initiatives Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 1.84% increase. The company also saw a substantial improvement in profitability, with a 26.96% increase in profit. The company's net worth Soared by an impressive increase of 17.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Initiatives?
In 2019, Biotech Initiatives had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Deenam Fashion Private LimitedActive 5 years 8 monthsDeepak Prajapati and Poonam Prajapati are mutual person
- Avatalife Agro-Trade Private LimitedActive 6 years 5 months
Deepak Prajapati and Poonam Prajapati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 24 Jul 2020 | ₹4.00 M | Open |
Others Creation Date: 31 Jan 2019 | ₹5.05 Cr | Open |
Others Creation Date: 10 May 2018 | ₹2.80 Cr | Open |
How Many Employees Work at Biotech Initiatives?
Unlock and access historical data on people associated with Biotech Initiatives, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Initiatives, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Initiatives's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
